ABUS vs APH
Arbutus Biopharma Corp (ABUS) versus Amphenol Corporation (APH) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Amphenol Corporation (APH) is a electronic components company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Not investment advice. Open the ABUS and APH stock pages for the full models.
Not investment advice.